Long PBM signal by Rajiv Menon

PBM looks LONG to me Observation: the news is not just chatter — they started patient dosing in the Phase IIb trial, and the ibogaine supply story is getting real attention, so this one still has a pulse 😶. Macro view: when the market gets a bit hungry for fresh small-cap stories, even messy names can catch a bid if there is a live catalyst and a bit of liquidity behind it. Principle: don’t do that lazy thing where you call every strong move fake just because you missed it; tape can stay wild,